Oxford vaccine recipients developing antibody in Bangladesh

[Destranator]

Oxford vaccine recipients developing antibody in Bangladesh

The vaccine recipients, who had already been infected with Covid-19, developed the antibodies four times more than the non-infected vaccine receivers
File Photo: PID

File Photo: PID

People, who received the Oxford-AstraZeneca vaccine in Bangladesh, are developing antibodies against Covid-19, finds a study.
After the first month of the vaccination, 120 recipients developed 92% antibodies. The percentage went up to 97% after two months, found in the research jointly conducted by Institute of Epidemiology Disease Control And Research (IEDCR) and International Centre for Diarrhoeal Disease Research, Bangladesh (icddrb).
The presence of antibodies against Covid-19 has been found among all vaccine receivers irrespective of age.

Furthermore, no significant differences were found in the presence of antibodies between healthy people and those with comorbidities.

In addition, the vaccine recipients, who had already been infected with Covid-19, developed the antibodies four times more than the non-infected vaccine receivers.

IEDCR and icddrb will have been observing the presence of the antibodies in the blood of 6,300 vaccine recipients for the next two years.

Oxford vaccine recipients developing antibody in Bangladesh

The vaccine recipients, who had already been infected with Covid-19, developed the antibodies four times more than the non-infected vaccine receivers

www.tbsnews.net

 

[Bilal9]

So once infected, the rate of antibody development naturally should go up (even without vaccine). I guess vaccine just boosts the process (which is what vaccines should do).

But I have heard that some folks who received vaccines in the US and went to India, later got re-infected and passed away.

Something to say about different COVID variants and mutations.

 

[UKBengali]

Some good news about the efficacy of AstraZeneca vaccine against one of the Indian variants.

15 double-dose vaccinated elderly residents in a care home in the UK got infected with this variant. 4 were hospital with non-severe disease and then discharged.

It seems that the AstraZeneca vaccine that BD has been using is highly effectve against at least one of the new India variants.

 

[Destranator]

Some good news about the efficacy of AstraZeneca vaccine against one of the Indian variants.

15 double-dose vaccinated elderly residents in a care home in the UK got infected with this variant. 4 were hospital with non-severe disease and then discharged.

It seems that the AstraZeneca vaccine that BD has been using is highly effectve against at least one of the new India variants.

I really hope we get the damn licence. BD should intensify lobbying in this regard.

 

[Rahil khan]

Any blood clotting cases reported in Bangladesh or any other developing country ??

 

[Bilal9]

Any blood clotting cases reported in Bangladesh or any other developing country ??

No serious issues post vaccination, certainly no blood clotting. Seems to be a European thing mostly for EU women between 18-48. IMHO blood clotting may be unrelated to the vaccines themselves.

No blood clotting in Covid-19 vaccine takers in Bangladesh

Vaccine takers have reported 897 adverse events so far, but all of them were minor and there were no signs of blood clotting

www.dhakatribune.com

 

[UKBengali]

No serious issues post vaccination, certainly no blood clotting. Seems to be a European thing mostly for EU women between 18-48. IMHO blood clotting may be unrelated to the vaccines themselves.

No blood clotting in Covid-19 vaccine takers in Bangladesh

Vaccine takers have reported 897 adverse events so far, but all of them were minor and there were no signs of blood clotting

www.dhakatribune.com

There is a definite link between viral-vector vaccines like AstraZeneca and Johnson & Johnson with rare risk of blood clots - it is 1 in 100,000 for AstraZeneca in the UK with 1 in 500,000 deaths and so your risk of even developing a blood clot is extremely rare, let alone dying if you have access to the right medical care.

Yes from the data in both BD and UK it looks like the issues are mainly to do with the under 50s and so BD can just forge ahead with AstraZeneca dosing as soon as it hopefully gets it hands on those spare doses from the US and exports from India resume again.

 

[Vikki]

Some good news about the efficacy of AstraZeneca vaccine against one of the Indian variants.

15 double-dose vaccinated elderly residents in a care home in the UK got infected with this variant. 4 were hospital with non-severe disease and then discharged.

It seems that the AstraZeneca vaccine that BD has been using is highly effectve against at least one of the new India variants.

Read this

Indian double mutant variant of Covid-19 less severe for vaccinated: Study

The B.1.617 variant first emerged in Maharashtra towards the end of 2020 and has spread throughout India and to at least 40 countries

wap.business-standard.com

Vaccines 'almost certainly less effective' against B1.617.2 transmission: UK expert

A leading UK scientist who advises the country's vaccination programme said on Saturday that vaccines being administered to protect against Covid-19 are "almost certainly less effective" against preventing the transmission of the B1.617.2 variant first identified in India.

www.indiatoday.in